endospore-forming bacillus, strain BMG287-AF7 (isolated from a soil sample collected in Nagano Prefecture, Japan) were found to inhibit ß-lactamases. These fatty acids were first obtained as a mixture of C14~C17 fatty acids.1) From this mixture 12-methyltetradecanoic acid (a-C15),2) 12-methyltridecanoic acid (i-C14), 14-methylpentadecanoic acid (i-C16), hexadecanoic acid (n-C16) and 14-methylhexadecanoic acid (a-C17) were isolated by high-performance liquid chromatography (HPLC). The main component was a-C15. The structure of each fatty acid in the mixture was determined by comparison of their behaviors in gas chromatography (GC) with authentic samples supplied by Dr. T.
K.ANEDA1) and their structures were confirmed by mass spectrometry and 1H-and 13C-NMR. In this report, we will report the activity of these fatty acids and their analogs as inhibitors of penicillinases (PCases) and cephalosporinases (CSases).
Experimental
Chemicals and Microorganisms Potassium benzylpenicillin (PCG), ampicillin (ABPC), carbenicillin (CBPC), and cephaloridine (CER), supplied as standards for assay from National Institute of Health, Japan, were employed as substrates for ß-lactamase reactions. Tetradecanoic (n-C14), pentadecanoic (n-C15) and heptadecanoic (n-C17) acids were purchased from Sigma Chemical Co., Ltd.
13-Methyltetradecanoic acid (i-C15) was isolated during a previous search for inhibitors of reverse transcriptase (unpublished). The fatty acid was assayed as an inhibitor of ß-lactamases in the study reported here.
Escherichia coli ML2825 producing PCase TEM type, E. coli K-12 W3630/Rms212 producing PCase type I, E. coli K-12 W3630/Rms213 producing PCase type II, Pseudomonas aeruginosa M1/ Rms139 producing PCase type IV, Citrobacter freundii GN346 producing CSase, C. freundii GN7391 producing CSase and Enterobacter cloacae GN5797 producing CSase were supplied by Prof. S. MITSU-HASHI, Gunma University, Japan, and they were used as ß-lactamase producers. Staphylococcus aureus FDA209P was used as the assay organism. ** To whom correspondence should be addressed .
Preparation of ß-Lactamases3) To 100 ml of heart infusion broth (Difco Laboratories) placed in a 500-m1 Sakaguchi flask 10 ml of a 18-hour culture of a 33lactamase-producing strain was added. The culture was then incubated for 5 hours at 37°C on a reciprocal shaker (120 strokes/minute).
To induce CSase production, PCG (0.5 mg/ml) was added to the 2-hour culture of C. freundii GN346, C. freundii GN7391 or Ent. cloacae GN5797 and the incubation was continued for 3 hours. Following incubation, bacterial cells were collected by centrifugation, washed twice with saline water and resuspended in 0.1 M phosphate buffer (pH 7.0), at a concentration of 40 to 60 mg (wet cell weight)/ml. The suspension was passed through a French pressure cell (70 kg/cm2) and then centrifuged at 100,000 g for 2 hours. The clear supernatant ß-lactamase solution) was divided into small portions and stored at -80°C . One unit of ß-lactamase activity was defined as the amount of enzyme which hydrolyzed one micrornole of substrate per minute at 25°C in pH 7.0 buffer solution.
Determination of 3-Lactamase-inhibiting Activity by Plate Method A paper disc (8 mm in diameter), which absorbed 40 µd of sample solution , was placed on a test plate (90 mm in diameter). The nutrient agar medium in the test plate was prepared by mixing 0.5 ml of the ß-lactamase solution, 0.5 nil of an aqueous solution of a substrate, 9.0 ml of nutrient agar and 0.1 nil of an overnight culture of Staph. aureus FDA209P. To assay for inhibition of PCase activity, PCG (62.7 µg/nil) was used as the substrate and PCase (0.0068 unit/ml) obtained from E. coil ML2825 was used as the ß-lactamase.
CER (104 µg/ml) and CSase (0.01 unit/ml) obtained from C. freundii GN346 were used for the assay of CSase-inhibiting activity. After incubation of the test plate at 37 C for 16 hours, the inhibition zone against Staph. aureus FDA209P was measured. The activity of an inhibitor was expressed by taking the activity of a-C15 as the standard (1,000 µg units/mg). In the assay for PCase-inhibiting activity, a-C15 at 1,000 µg/ml showed about a 17-mm zone of inhibition.
For reference, the antibiotic activity of an inhibitor was determined by using a plate containing 10 ml of nutrient agar and 0.1 ml of a culture of Staph. aureus FDA209P.
Determination of ;-j-Lactamase-inhibiting Activity by UV Method Lactamase solution was diluted in 0.05 M phosphate buffer (pH 7.0) until it gave 80% hydrolysis of the substrate in 20 minutes at 25°C. ß-Lactamase-inhibiting activity (I50) was determined by the spectrophotometric method at 25°C.4,5) The decrease in optical density at 240 nm for PCG, ABPC and CBPC, and at 255 nm for CER was recorded. The enzyme was pre-incubated with each inhibitor at 25°C for 15 minutes and thereafter the enzyme reaction was started by the addition of a substrate.
Isolation of Fatty Acids from Cultured Broth of a Bacillus Strain BMG287-AF7, a Gram-positive, endospore-forming bacillus, was cultured at 28°C on a rotatory shaker (180 rpm) in a 500-m1 Erlenmeyer flask containing 110 ml of a medium (2.0% galactose, 2.0% dextrin, 1.0% soy peptone, 0.5% corn steep liquor, 0.2% (NH4)2SO4 and 0.2% CaCO3, adjusted to pH 7.4). The 72-hour culture was inoculated to fresh medium in 45 flasks at 2.0% by volume and incubated for 24 hours. The cultured broths were combined and 3.0 liters of the broth were obtained. The activity of 1 ml was 140 µg units. Inhibitors in the combined broth were extracted with a mixture of ethyl acetate (5.0 liters) and 1-butanol (1.5 liters), and the extract was concentrated to dryness (9.4 g). The residue was extracted with acetone (250 ml) and the extract was evaporated to yield a crude powder (6.87 g, 34 µg units/mg). The crude powder was subjected to column chromatography of silica gel (Wakogel C-200, 300 g) developed with a mixture of toluene and ethyl acetate Identification of Fatty Acids by GC After methylation of each component with diazomethane in a methanol solution, each ester was analyzed by GC (Shimadzu GC-4CM, column; 15% DEGS-Neopak 1A 6080, 0.3×200cm, tear perature; 165°C, carrier gas; N2, flow rate; 30 ml/minute, detector; FID).
Results and Discussion
An active principle which inhibits ß-lactantases, found in the culture broth of a bacillus strain, has been shown to be a mixture of fatty acids. The mixture of fatty acids was separated into five components by preparative H PLC. These components 1 ~5 were converted into their methyl esters and the esters of the components 1 ~5 were identified by GC to be the methyl esters Of i-C14, a-C15, i-C16, n-C16, and a-C17, respectively. Properties of these fatty acids are shown in Table 1 . Prior to this work, a-C15 (sarcinic acid) had been reported as a major acid in lipids of Sarcina sp.,2) Bacillus sabtilis,1)
Micrococcus Iysodeikticus4' and rumen bacteria.' Table  1 . Properties of fatty acids obtained from a bacterial culture. As shown in Table 2 , this acid (a-C15, component 2) showed the strongest activity in inhibiting ß-lactamases, in comparison with i-C14 (component 1), n-C14, i-C15, n-C15, i-C16 (component 3), n-C16 (component 4), a-C17 (component 5) and n-C117 Although the activity was weaker, the other fatty acids except n-C14 and n-C15 exhibited an activity in inhibiting ß-lactamases. n-C14 and n-C15 were inactive.
It is interesting that a-C15 exhibited a relatively strong activity against PCases produced by E. coli ML-2825, E. coli K-12 W3630/Rms212 and P. aeruginosa M1/Rms139. Moreover, the 1-methylpropyl structure was suggested to be an interesting structure in inhibiting ß-lactamases, because a-C17 was more active than n-C17 and a-C15 than i-C15 or n-C15.
All fatty acids described above had no activity in inhibiting the growth of Staph. aureus FDA209P, when they were tested at concentrations of 4 mg/ml.
